BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36890161)

  • 21. Rare SERINC2 variants are specific for alcohol dependence in individuals of European descent.
    Zuo L; Wang KS; Zhang XY; Li CS; Zhang F; Wang X; Chen W; Gao G; Zhang H; Krystal JH; Luo X
    Pharmacogenet Genomics; 2013 Aug; 23(8):395-402. PubMed ID: 23778322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.
    Bakken TE; Bloss CS; Roddey JC; Joyner AH; Rimol LM; Djurovic S; Melle I; Sundet K; Agartz I; Andreassen OA; Dale AM; Schork NJ
    Arch Gen Psychiatry; 2011 Aug; 68(8):781-90. PubMed ID: 21810643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
    Voineskos AN; Felsky D; Wheeler AL; Rotenberg DJ; Levesque M; Patel S; Szeszko PR; Kennedy JL; Lencz T; Malhotra AK
    Schizophr Bull; 2016 Jul; 42(4):1027-36. PubMed ID: 26712857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common variants at 1p36 are associated with superior frontal gyrus volume.
    Hashimoto R; Ikeda M; Yamashita F; Ohi K; Yamamori H; Yasuda Y; Fujimoto M; Fukunaga M; Nemoto K; Takahashi T; Tochigi M; Onitsuka T; Yamasue H; Matsuo K; Iidaka T; Iwata N; Suzuki M; Takeda M; Kasai K; Ozaki N
    Transl Psychiatry; 2014 Oct; 4(10):e472. PubMed ID: 25335168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide significant association signals in IPO11-HTR1A region specific for alcohol and nicotine codependence.
    Zuo L; Zhang XY; Wang F; Li CS; Lu L; Ye L; Zhang H; Krystal JH; Deng HW; Luo X
    Alcohol Clin Exp Res; 2013 May; 37(5):730-9. PubMed ID: 23216389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcortical structures associated with childhood trauma and perceived stress in schizophrenia.
    Fan F; Tan S; Liu S; Chen S; Huang J; Wang Z; Yang F; Li CR; Tan Y
    Psychol Med; 2023 Sep; 53(12):5654-5662. PubMed ID: 36154670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.
    Franke B; Stein JL; Ripke S; Anttila V; Hibar DP; van Hulzen KJE; Arias-Vasquez A; Smoller JW; Nichols TE; Neale MC; McIntosh AM; Lee P; McMahon FJ; Meyer-Lindenberg A; Mattheisen M; Andreassen OA; Gruber O; Sachdev PS; Roiz-Santiañez R; Saykin AJ; Ehrlich S; Mather KA; Turner JA; Schwarz E; Thalamuthu A; Shugart YY; Ho YY; Martin NG; Wright MJ; ; ; O'Donovan MC; Thompson PM; Neale BM; Medland SE; Sullivan PF
    Nat Neurosci; 2016 Mar; 19(3):420-431. PubMed ID: 26854805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergent Evidence for Predispositional Effects of Brain Gray Matter Volume on Alcohol Consumption.
    Baranger DAA; Demers CH; Elsayed NM; Knodt AR; Radtke SR; Desmarais A; Few LR; Agrawal A; Heath AC; Barch DM; Squeglia LM; Williamson DE; Hariri AR; Bogdan R
    Biol Psychiatry; 2020 Apr; 87(7):645-655. PubMed ID: 31699293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
    Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
    Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.
    Oertel-Knöchel V; Lancaster TM; Knöchel C; Stäblein M; Storchak H; Reinke B; Jurcoane A; Kniep J; Prvulovic D; Mantripragada K; Tansey KE; O'Donovan MC; Owen MJ; Linden DE
    Neuroimage Clin; 2015; 7():764-70. PubMed ID: 25844328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.
    Xiao X; Zhang C; Grigoroiu-Serbanescu M; Wang L; Li L; Zhou D; Yuan TF; Wang C; Chang H; Wu Y; Li Y; Wu DD; Yao YG; Li M
    Mol Psychiatry; 2018 Sep; 23(9):1957-1967. PubMed ID: 29158582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function.
    Smeland OB; Frei O; Kauppi K; Hill WD; Li W; Wang Y; Krull F; Bettella F; Eriksen JA; Witoelar A; Davies G; Fan CC; Thompson WK; Lam M; Lencz T; Chen CH; Ueland T; Jönsson EG; Djurovic S; Deary IJ; Dale AM; Andreassen OA;
    JAMA Psychiatry; 2017 Oct; 74(10):1065-1075. PubMed ID: 28746715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings.
    Navarri X; Afzali MH; Lavoie J; Sinha R; Stein DJ; Momenan R; Veltman DJ; Korucuoglu O; Sjoerds Z; van Holst RJ; Hester R; Orr C; Cousijn J; Yucel M; Lorenzetti V; Wiers R; Jahanshad N; Glahn DC; Thompson PM; Mackey S; Conrod PJ
    Hum Brain Mapp; 2022 Jan; 43(1):399-413. PubMed ID: 32643841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex.
    Guella I; Sequeira A; Rollins B; Morgan L; Torri F; van Erp TG; Myers RM; Barchas JD; Schatzberg AF; Watson SJ; Akil H; Bunney WE; Potkin SG; Macciardi F; Vawter MP
    J Psychiatr Res; 2013 Sep; 47(9):1215-21. PubMed ID: 23786914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
    Carroll LS; Williams NM; Moskvina V; Russell E; Norton N; Williams HJ; Peirce T; Georgieva L; Dwyer S; Grozeva D; Greene E; Farmer A; McGuffin P; Morris DW; Corvin A; Gill M; Rujescu D; Sham P; Holmans P; Jones I; Kirov G; Craddock N; O'Donovan MC; Owen MJ
    Mol Psychiatry; 2010 Nov; 15(11):1101-11. PubMed ID: 19786960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participants.
    Quidé Y; Matosin N; Atkins JR; Fitzsimmons C; Cairns MJ; Carr VJ; ; Green MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():12-20. PubMed ID: 29247760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
    Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
    Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.
    Toma C; Pierce KD; Shaw AD; Heath A; Mitchell PB; Schofield PR; Fullerton JM
    PLoS Genet; 2018 Dec; 14(12):e1007535. PubMed ID: 30586385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder.
    de Zwarte SMC; Brouwer RM; Agartz I; Alda M; Aleman A; Alpert KI; Bearden CE; Bertolino A; Bois C; Bonvino A; Bramon E; Buimer EEL; Cahn W; Cannon DM; Cannon TD; Caseras X; Castro-Fornieles J; Chen Q; Chung Y; De la Serna E; Di Giorgio A; Doucet GE; Eker MC; Erk S; Fears SC; Foley SF; Frangou S; Frankland A; Fullerton JM; Glahn DC; Goghari VM; Goldman AL; Gonul AS; Gruber O; de Haan L; Hajek T; Hawkins EL; Heinz A; Hillegers MHJ; Hulshoff Pol HE; Hultman CM; Ingvar M; Johansson V; Jönsson EG; Kane F; Kempton MJ; Koenis MMG; Kopecek M; Krabbendam L; Krämer B; Lawrie SM; Lenroot RK; Marcelis M; Marsman JC; Mattay VS; McDonald C; Meyer-Lindenberg A; Michielse S; Mitchell PB; Moreno D; Murray RM; Mwangi B; Najt P; Neilson E; Newport J; van Os J; Overs B; Ozerdem A; Picchioni MM; Richter A; Roberts G; Aydogan AS; Schofield PR; Simsek F; Soares JC; Sugranyes G; Toulopoulou T; Tronchin G; Walter H; Wang L; Weinberger DR; Whalley HC; Yalin N; Andreassen OA; Ching CRK; van Erp TGM; Turner JA; Jahanshad N; Thompson PM; Kahn RS; van Haren NEM
    Biol Psychiatry; 2019 Oct; 86(7):545-556. PubMed ID: 31443932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.